Cristin-person-ID: 51982
Person

Per Eystein Lønning

  • Stilling:
    Overlege / forsker
    ved Avdeling for kreftbehandling og medisinsk fysikk ved Helse Bergen HF - Haukeland universitetssykehus
  • Stilling:
    Professor
    ved Klinisk institutt 2 ved Universitetet i Bergen

Kontaktinformasjon

Resultater

Genomic evolution and therapy resistance in melanoma and breast cancer.

Birkeland, Einar Elvbakken; Lønning, Per Eystein; Knappskog, Stian. 2018, UIBDoktorgradsavhandling

Divergent activity of the pseudogene PTENP1 in ER-positive and negative breast cancer.

Yndestad, Synnøve; Austreid, Eilin; Skaftnesmo, Kai Ove; Lønning, Per Eystein; Eikesdal, Hans Petter. 2018, Molecular Cancer Research. HAUKELAND, UIBVitenskapelig artikkel

Double KRAS and BRAF mutations in surgically treated colorectal cancer liver metastases: An international, multi-institutional case series.

Deshwar, Amar; Margonis, Georgios Antonios; Andreatos, Nikolaos; Barbon, Carlotta; Wang, Jaeyun; Buettner, Stefan; Wagner, Doris; Sasaki, Kazunari; Beer, Andrea; Løes, Inger Marie mfl.. 2018, Anticancer Research. SU, MEDUNIGRAZ, CLEVELAND, UOA, HAUKELAND, JHSM, CHARITE, MUW, UIBVitenskapelig artikkel

The prognosis of colorectal cancer liver metastases associated with inflammatory bowel disease: An exploratory analysis.

Margonis, Georgios Antonios; Buettner, Stefan; Andreatos, Nikolaos; Wagner, Doris; Sasaki, Kazunari; Galjart, Boris; Kamphues, Carsten; Pawlik, Timothy M.; Poultsides, George; Kaczirek, Klaus mfl.. 2018, Journal of Surgical Oncology. SU, MEDUNIGRAZ, CLEVELAND, HAUKELAND, EMC, JHSM, TOSU, CHARITE, MUW, UIBVitenskapelig artikkel

Buparlisib plus fulvestrant in postmenopausal women with hormone-receptor-positive, HER2-negative, advanced breast cancer progressing on or after mTOR inhibition (BELLE-3): a randomised, double-blind, placebo-controlled, phase 3 trial.

Di Leo, Angelo; Johnston, Stephen; Lee, Keun Seok; Ciruelos, Eva; Lønning, Per Eystein; Janni, Wolfgang; O'Regan, Ruth; Mouret-Reynier, Marie-Ange; Kalev, Dimitar; Egle, Daniel mfl.. 2018, The Lancet Oncology. UU, USA, MEDINNSBRU, H12O, HAUKELAND, MARSDEN, UIB, MuV, SSN, INSERM, TUMORI, CLB, UM, NOVARTIS, MTA, TYSKLAND, UoW, NCCIVitenskapelig artikkel